🇺🇸 QUINIDINE POLYGALACTURONATE in United States

FDA authorised QUINIDINE POLYGALACTURONATE on 16 June 1999

Marketing authorisations

FDA — authorised 16 June 1999

  • Application: NDA011642
  • Marketing authorisation holder: PHARM RES ASSOC
  • Local brand name: CARDIOQUIN
  • Indication: TABLET — ORAL
  • Status: approved

Read official source →

FDA

  • Status: approved

QUINIDINE POLYGALACTURONATE in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is QUINIDINE POLYGALACTURONATE approved in United States?

Yes. FDA authorised it on 16 June 1999; FDA has authorised it.

Who is the marketing authorisation holder for QUINIDINE POLYGALACTURONATE in United States?

PHARM RES ASSOC holds the US marketing authorisation.